Fit India and Bangalore Diabetes Club Announce Insulin Injection Recommendations for Elderly Living with Diabetes

Printer-friendly versionPrinter-friendly version

92 years ago, in Toronto General Hospital on 11th January, 1922, a novel invention changed the lives of millions living with Diabetes & revolutionized its management

Bangalore, Karnataka, January 22, 2014 -- 92 years ago, in Toronto General Hospital on 11th January, 1922, a novel invention changed the lives of millions living with Diabetes & revolutionized its management, particularly Type I diabetes. Observing the insulin injection week in India starting 11th January, The Forum for Injection Technique (FIT) India and Bangalore Diabetes Club today announced injection recommendations for elderly people living with diabetes in the city.

Dr. K M Prasanna kumar, Consultant Endocrinologist & Executive Advisory Member, FIT India said, “Insulin remains a critical component of treatment of Diabetes, not only type I but also in many cases of Type II. At present injection remains the only practical means to deliver insulin. It is a welcome move that a day has been dedicated to deliberate on Insulin Injection by FIT. This should have a favorable impact on the acceptance of insulin injection among both physicians and patients.

Counseling elderly or geriatric patients for self-injection can be a challenging task. Unlike their younger peers, they may have certain age related potential difficulty in executing the instructions for injections properly. The FIT recommendations suggest that physicians should not use age as an excuse to avoid usage of insulin which can delay the treatment and result in further complications. Along with insulin initiation for elderly patients, health-care providers must ensure the involvement of responsible family members/attendants during the selection of insulin and explanation of injection technique.

According to Dr. C. Munichoodappa , Head, Department of Diabetology, Bangalore Hospital, “As per latest survey, more than 15% of diabetic patients in the city do not adhere to appropriate insulin treatment practices, and 20% do not know about right injection techniques. As insulin treatment is vital for blood glucose control, inappropriate injection skills compromise the dosage accuracy and its effectiveness. Moreover, it may also lead to pain with bleeding and a risk of contamination.”

Dr. Kumar added, “FIT India is dedicated to raise awareness on correct injection practices for an effective and safe diabetes therapy management and compliance. In the past one year FIT has launched the first ever India-specific clinical recommendations for appropriate insulin injection techniques and reached out to more than 100 hospitals and 50 HCPs and patients. With these recommendations we aim to bring uniformity in insulin injection technique throughout the country and help impart the right education to both healthcare providers and people living with diabetes.”

A scientific advisory board of well-known endocrinologists and diabetes experts compiled the FIT India recommendations based on clinical evidence, implications for patient therapy and the judgment of a group of experts in order to promote best practices in injection technique and bring uniformity in insulin injection technique diabetes patients and healthcare professionals.

Insulin injection recommendations

Needle length

  • For children and adolescents, a 4, 5, or 6 mm needle should be used. A1

  • Adults, including obese patients, can use 4, 5, and 6 mm needle length. A1

Site rotation

  • An easy-to-follow rotation scheme should be taught to the patients from the onset of injection therapy. A2

Needle/syringe hygiene

  • Do not reuse needles. A2

  • Use a new needle for each injection. A2


  • Injection sites should be inspected at every visit. Patients should be taught to inspect their own sites and should also be given training on how to detect lipohypertrophy. A2

  • The best current strategies to prevent and treat lipohypertrophy are to rotate the injection sites with each injection, using larger injecting zones and non-reuse of needles. A2

Injection sites

  • Injection should be given at a clean site with clean hands. A2

  • Prior to the injection, the site has to be palpated for lipohypertrophy and inspected for wounds, bruises, or blisters. If the injection site shows any signs of these, then a different site should be selected until the problem has been resolved. A3

Safety issues

  • Safety needles should be recommended whenever there is a risk for a contaminated needle-stick injury. B1

According to     Dr. Syed Javaz, Medical Superintendent & Director, Bangalore Diabetes Hospital, “30% of people have psychological resistance to even initiate an insulin therapy, despite it being indispensible for glycemic control to manage the disease. The recommendations by FIT India have been immensely helpful in optimizing insulin injection technique for both healthcare workers and patients and have improved the overall acceptance of insulin delivery and injections.”
Several factors, including method of administration, dosing, compliance, selection of injection site, depth of the injection, time lapse before withdrawing the needle and misconceptions about insulin therapy, influence the success of insulin injection therapy.

In November 2012 Forum for Injection Techniques (FIT India) and BD India had come together to launch the first Indian clinical recommendations for best practices in insulin injection techniques in India.

About FIT India:
FIT is an autonomous organisation whose overarching mission is to support people with diabetes using injectable therapies to achieve the best possible health outcomes that can be influenced by correct injection technique. The development of FIT and the subsequent India recommendations for injection technique have been supported by prominent medical technology firm Becton, Dickinson & Co. (BD India). FIT is committed to supporting the implementation of the recommendations by all those involved in diabetes care and developing the recommendations further.

About Bangalore Diabetes Club:
The Bangalore Diabetes Club was established in 2007 and meant to bring together anyone having Type-1 diabetes and their families in and around Bangalore. The objective of the club is to share positive experiences and professional advice to help members master the art of diabetes management, including health as well as social aspects, and lead normal and successful lives. The club focuses on discussions on group therapy, diabetes care and family education of Type-1 diabetes, and discussion of common challenges (physical, psychological and social) faced by people having Type-1 diabetes. The club has regular academic activities including regular scientific meetings, CMEs, annual conferences at local/state level providing an easily accessible platform for their members to update, interact, discuss and learn more about the recent developments in diabetes, thereby empowering them to provide better care for diabetes patients.

Press Contact:
Nitheen A S
#24/1, Walker Lane
Langford road cross, Richmond town
Bangalore 560025
+91 80 41233493
Email partially hidden to block spam. Please use the contact form here.
Contact Nitheen A S
Email the contact person for this press release. Do not send spam or irrelevant message.
3 + 7 =

Copy this html code to your website/blog to embed this press release.


Post new comment

6 + 8 =

To prevent automated spam submissions leave this field empty.
Page execution time was 666.85 ms.

Memory usage:

Memory used at: devel_init()=2.13 MB, devel_shutdown()=22.64 MB.